Clinical Trial Update: Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a fixed combination therapy (timolol-brimonidine-dorzolamide) for primary open-angle glaucoma and ocular hypertension has completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Timolol-Brimonidine-Dorzolamide fixed combination

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-08-01